TYK Medicines (HKSE:02410) ROCE % : 0.00% (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is TYK Medicines ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. TYK Medicines's annualized ROCE % for the quarter that ended in Jun. 2024 was 0.00%.

TYK Medicines ROCE % Historical Data

The historical data trend for TYK Medicines's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TYK Medicines ROCE % Chart

TYK Medicines Annual Data

Trend

Dec22

Dec23

Dec24

ROCE %

TYK Medicines Quarterly Data
	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial			-	-	-	-	-

TYK Medicines ROCE % Calculation

TYK Medicines's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-409.558	/	( ( (623.53 - 1074.548)	+	(626.886 - 1422.983) )	/ 2 )
	=	-409.558	/	( (-451.018	+	-796.097)	/ 2 )
	=	-409.558	/	-623.5575
	=	65.68 %

TYK Medicines's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	-468.016	/	( ( (655.032 - 1490.739)	+	(569.811 - 1517.631) )	/ 2 )
	=	-468.016	/	( ( -835.707	+	-947.82 )	/ 2 )
	=	-468.016	/	-891.7635
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

TYK Medicines (HKSE:02410) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

TYK Medicines ROCE % Related Terms

Thank you for viewing the detailed overview of TYK Medicines's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

TYK Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TYK Medicines Inc (HKSE:02410) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1278 Mingzhu Road, Room 1403-2, Floor 14, Tower A, Changxing World Trade Building, Zhejiang Province, Changxing Economic Development Zone, Huzhou, CHN

Website

http://www.tykmedicines.com

TYK Medicines Inc is a drug discovery research and development centre. The company and its subsidiaries are principally engaged in the research, development and commercialization of pharmaceutical products.

Executives

Nan Jing Yi Da Tou Zi Guan Li You Xian Gong Si
Nan Jing Yi Da Zi Ben Guan Li Qi Ye You Xian He Huo
Jiang Su Yi Da Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Wu Yusheng	2201 Interest of corporation controlled by you
Zhu Julia Ming	2202 Interest of your spouse
Zheng Zhou Tai Ji Hong Nuo Yi Yao Gu Fen You Xian Gong Si	2101 Beneficial owner
Zhang Xing Li Yuan Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
He Chao	2201 Interest of corporation controlled by you
Bei Jing Hou Ji Jing Qiao Chuang Ye Tou Zi You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Rong Chen Hou Ji Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Zhang Xing Xing Zhang Chan Ye Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner

TYK Medicines Headlines

No Headlines